PMID- 24118418 OWN - NLM STAT- MEDLINE DCOM- 20140716 LR - 20131202 IS - 1460-9568 (Electronic) IS - 0953-816X (Linking) VI - 38 IP - 11 DP - 2013 Dec TI - Blocking brain-derived neurotrophic factor inhibits injury-induced hyperexcitability of hippocampal CA3 neurons. PG - 3554-66 LID - 10.1111/ejn.12367 [doi] AB - Brain trauma can disrupt synaptic connections, and this in turn can prompt axons to sprout and form new connections. If these new axonal connections are aberrant, hyperexcitability can result. It has been shown that ablating tropomyosin-related kinase B (TrkB), a receptor for brain-derived neurotrophic factor (BDNF), can reduce axonal sprouting after hippocampal injury. However, it is unknown whether inhibiting BDNF-mediated axonal sprouting will reduce hyperexcitability. Given this, our purpose here was to determine whether pharmacologically blocking BDNF inhibits hyperexcitability after injury-induced axonal sprouting in the hippocampus. To induce injury, we made Schaffer collateral lesions in organotypic hippocampal slice cultures. As reported by others, we observed a 50% reduction in axonal sprouting in cultures treated with a BDNF blocker (TrkB-Fc) 14 days after injury. Furthermore, lesioned cultures treated with TrkB-Fc were less hyperexcitable than lesioned untreated cultures. Using electrophysiology, we observed a two-fold decrease in the number of CA3 neurons that showed bursting responses after lesion with TrkB-Fc treatment, whereas we found no change in intrinsic neuronal firing properties. Finally, evoked field excitatory postsynaptic potential recordings indicated an increase in network activity within area CA3 after lesion, which was prevented with chronic TrkB-Fc treatment. Taken together, our results demonstrate that blocking BDNF attenuates injury-induced hyperexcitability of hippocampal CA3 neurons. Axonal sprouting has been found in patients with post-traumatic epilepsy. Therefore, our data suggest that blocking the BDNF-TrkB signaling cascade shortly after injury may be a potential therapeutic target for the treatment of post-traumatic epilepsy. CI - (c) 2013 Federation of European Neuroscience Societies and John Wiley & Sons Ltd. FAU - Gill, Raminder AU - Gill R AD - Department of Pharmacology & Therapeutics, McGill University, Bellini Life Sciences Complex, 3649 Promenade Sir William Osler, Montreal, QC, Canada, H3G 0B1. FAU - Chang, Philip K-Y AU - Chang PK FAU - Prenosil, George A AU - Prenosil GA FAU - Deane, Emily C AU - Deane EC FAU - McKinney, Rebecca A AU - McKinney RA LA - eng GR - Canadian Institutes of Health Research/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130930 PL - France TA - Eur J Neurosci JT - The European journal of neuroscience JID - 8918110 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Membrane Glycoproteins) RN - EC 2.7.10.1 (Ntrk2 protein, mouse) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) SB - IM CIN - Eur J Neurosci. 2013 Dec;38(11):3552-3. doi: 10.1111/ejn.12419. PMID: 24289826 MH - Animals MH - Axons/pathology MH - Brain Injuries/metabolism/*physiopathology MH - Brain-Derived Neurotrophic Factor/*deficiency MH - CA3 Region, Hippocampal/metabolism/pathology/*physiology MH - *Excitatory Postsynaptic Potentials MH - Membrane Glycoproteins/antagonists & inhibitors/metabolism MH - Mice MH - Mice, Inbred C57BL MH - Protein-Tyrosine Kinases/antagonists & inhibitors/metabolism MH - Pyramidal Cells/metabolism/pathology/physiopathology OTO - NOTNLM OT - GAP43 OT - axonal sprouting OT - brain-derived neurotrophic factor OT - organotypic hippocampal slices OT - post-traumatic epilepsy EDAT- 2013/10/15 06:00 MHDA- 2014/07/17 06:00 CRDT- 2013/10/15 06:00 PHST- 2011/10/21 00:00 [received] PHST- 2013/08/16 00:00 [revised] PHST- 2013/08/28 00:00 [accepted] PHST- 2013/10/15 06:00 [entrez] PHST- 2013/10/15 06:00 [pubmed] PHST- 2014/07/17 06:00 [medline] AID - 10.1111/ejn.12367 [doi] PST - ppublish SO - Eur J Neurosci. 2013 Dec;38(11):3554-66. doi: 10.1111/ejn.12367. Epub 2013 Sep 30.